These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31802572)

  • 41. Vitamin D Deficiency among Adults with History of Pulmonary Tuberculosis in Korea Based on a Nationwide Survey.
    Joo MH; Han MA; Park SM; Shin HH
    Int J Environ Res Public Health; 2017 Apr; 14(4):. PubMed ID: 28394278
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vitamin D deficiencies among tuberculosis patients in Africa: A systematic review.
    Keflie TS; Nölle N; Lambert C; Nohr D; Biesalski HK
    Nutrition; 2015 Oct; 31(10):1204-12. PubMed ID: 26333888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How can tuberculosis services better support patients with a diabetes co-morbidity? A mixed methods study in the Philippines.
    Oliveira Hashiguchi L; Cox SE; Edwards T; Castro MC; Khan M; Liverani M
    BMC Health Serv Res; 2023 Sep; 23(1):1027. PubMed ID: 37749519
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determinants of treatment failure among tuberculosis patients in Kandahar City, Afghanistan: A 5-year retrospective cohort study.
    Rahimi BA; Rahimy N; Mukaka M; Ahmadi Q; Hayat MS; Wasiq AW
    Int J Mycobacteriol; 2019; 8(4):359-365. PubMed ID: 31793506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of vitamin D supplementation in type 2 diabetes patients with pulmonary tuberculosis.
    Kota SK; Jammula S; Kota SK; Tripathy PR; Panda S; Modi KD
    Diabetes Metab Syndr; 2011; 5(2):85-9. PubMed ID: 22813409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: a potential role in the emergence of multidrug-resistance.
    Chang JT; Dou HY; Yen CL; Wu YH; Huang RM; Lin HJ; Su IJ; Shieh CC
    J Formos Med Assoc; 2011 Jun; 110(6):372-81. PubMed ID: 21741005
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low prevalence of diabetes mellitus in patients with tuberculosis in Cotonou, Benin.
    Ade S; Affolabi D; Agodokpessi G; Wachinou P; Faïhun F; Toundoh N; Békou W; Makpenon A; Ade G; Anagonou S; Harries AD
    Public Health Action; 2015 Jun; 5(2):147-9. PubMed ID: 26400387
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tuberculosis seasonality in the Netherlands differs between natives and non-natives: a role for vitamin D deficiency?
    Korthals Altes H; Kremer K; Erkens C; van Soolingen D; Wallinga J
    Int J Tuberc Lung Dis; 2012 May; 16(5):639-44. PubMed ID: 22410705
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low Vitamin-D Levels Combined with PKP3-SIGIRR-TMEM16J Host Variants Is Associated with Tuberculosis and Death in HIV-Infected and -Exposed Infants.
    Gupta A; Montepiedra G; Gupte A; Zeldow B; Jubulis J; Detrick B; Violari A; Madhi S; Bobat R; Cotton M; Mitchell C; Spector S;
    PLoS One; 2016; 11(2):e0148649. PubMed ID: 26872154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glycemic control monitoring in patients with tuberculosis and diabetes: a descriptive study from programmatic setting in Tamil Nadu, India.
    Gurukartick J; Murali L; Shewade HD; Jacob AG; Samy MM; Dheenadayal D; Aslesh OP; Marimuthu G; Ananthakrishnan R; Krishnan N
    F1000Res; 2019; 8():1725. PubMed ID: 32509275
    [No Abstract]   [Full Text] [Related]  

  • 51. Association of Pulmonary Tuberculosis and Diabetes in Mexico: Analysis of the National Tuberculosis Registry 2000-2012.
    Delgado-Sánchez G; García-García L; Castellanos-Joya M; Cruz-Hervert P; Ferreyra-Reyes L; Ferreira-Guerrero E; Hernández A; Ortega-Baeza VM; Montero-Campos R; Sulca JA; Martínez-Olivares Mde L; Mongua-Rodríguez N; Baez-Saldaña R; González-Roldán JF; López-Gatell H; Ponce-de-León A; Sifuentes-Osornio J; Jiménez-Corona ME
    PLoS One; 2015; 10(6):e0129312. PubMed ID: 26075393
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TREATMENT OUTCOMES AMONG DIABETIC PATIENTS WITH TUBERCULOSIS IN THAILAND.
    Satung J; Kaewkungwal J; Silachamroon U; Pokaew P; Rattanajiamrangsree S; Kasetjareon Y; Lawpoolsri S
    Southeast Asian J Trop Med Public Health; 2016 Nov; 47(6):1209-20. PubMed ID: 29634188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors.
    Banu Rekha VV; Balasubramanian R; Swaminathan S; Ramachandran R; Rahman F; Sundaram V; Thyagarajan K; Selvakumar N; Adhilakshmi AR; Iliayas S; Narayanan PR
    Indian J Med Res; 2007 Nov; 126(5):452-8. PubMed ID: 18160750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba Hospital, Malawi.
    Harries AD; Nyangulu DS; Kang'ombe C; Ndalama D; Glynn JR; Banda H; Wirima JJ; Salaniponi FM; Liomba G; Maher D; Nunn P
    Trans R Soc Trop Med Hyg; 1998; 92(3):343-7. PubMed ID: 9861414
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sputum smear conversion and treatment outcomes for tuberculosis patients with and without diabetes in Fiji.
    Prasad P; Gounder S; Varman S; Viney K
    Public Health Action; 2014 Sep; 4(3):159-63. PubMed ID: 26400803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased vitamin D receptor expression from macrophages after stimulation with M. tuberculosis among persons who have recovered from extrapulmonary tuberculosis.
    Fiske CT; Blackman A; Maruri F; Rebeiro PF; Huaman M; Kator J; Scott Algood HM; Sterling TR
    BMC Infect Dis; 2019 Apr; 19(1):366. PubMed ID: 31039752
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the Xpert MTB/RIF assay for the diagnosis of smear-negative pulmonary and extrapulmonary tuberculosis in Madagascar.
    Rakotoarivelo R; Ambrosioni J; Rasolofo V; Raberahona M; Rakotosamimanana N; Andrianasolo R; Ramanampamonjy R; Tiaray M; Razafimahefa J; Rakotoson J; Randria M; Bonnet F; Calmy A;
    Int J Infect Dis; 2018 Apr; 69():20-25. PubMed ID: 29408360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diabetes is a strong predictor of mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients from Mwanza, Tanzania.
    Faurholt-Jepsen D; Range N; PrayGod G; Jeremiah K; Faurholt-Jepsen M; Aabye MG; Changalucha J; Christensen DL; Grewal HM; Martinussen T; Krarup H; Witte DR; Andersen AB; Friis H
    Trop Med Int Health; 2013 Jul; 18(7):822-9. PubMed ID: 23648145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of diabetes mellitus amongst hospitalized tuberculosis patients at an Indian tertiary care center: A descriptive analysis.
    Pande T; Huddart S; Xavier W; Kulavalli S; Chen T; Pai M; Saravu K
    PLoS One; 2018; 13(7):e0200838. PubMed ID: 30021016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vitamin D as adjunctive therapy in refractory pulmonary tuberculosis: a case report.
    Yamshchikov AV; Oladele A; Leonard MK; Blumberg HM; Ziegler TR; Tangpricha V
    South Med J; 2009 Jun; 102(6):649-52. PubMed ID: 19434014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.